NSCLC is a highly heterogeneous tumor with cells expressing putative stem cell markers such as aldehyde dehydrogenase (ALDH), ABCG2, CD44, CD133 and embryonic stem cell (ESC) markers, e.g., Sox2, Oct4 and Nanog [5]. This evidence concerns the gene LDHA and non-small cell lung carcinoma.